Scienture says hypertension drug Arbli added to formularies at three US pediatric academic medical centers

Scienture Holdings says its hypertension drug Arbli has been added to formularies at three US pediatric academic medical centers and hospitals, covering roughly 72 million prescriptions annually, according to an exclusive report.

Detected & updated continuously · Source: Nebula